IMPAX CV OUTBOUND (RESULTS MANAGEMENT 2.08)
Report
- Report Number
- 1225058-2014-00290
- Event Type
- Malfunction
- Date Received
- June 17, 2014
- Date of Event
- May 21, 2014
- Report Date
- June 18, 2014
- Manufacturer
- AGFA HEALTHCARE CORP.
- Product Code
- LLZ
- PMA / PMN Number
- K050228
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
AN AGFA CLINICAL ANALYST PERFORMED A RETRO-ANALYSIS AND REPORTED THE FINDINGS TO AGFA SERVICE AND AGFA PRODUCT QUALITY MANAGER. AGFA'S INVESTIGATION INTO THIS OCCURRENCE OF RMAT CUSTOMIZATIONS HAS REVEALED THAT THIS SPECIFIC CHANGE HAD THE POTENTIAL TO INTRODUCE CLINICAL INACCURACIES IN PATIENT REPORTS. SPECIFICALLY: FINDING SENTENCE FOR FINDING ID (B)(6) HAS BEEN CHANGED FROM "THE AORTIC VALVE LEAFLETS ARE SEVERELY THICKENED WITH REDUCED SYSTOLIC EXCURSION." TO "THE AORTIC VALVE LEAFLETS ARE THICKENED WITH REDUCED SYSTOLIC EXCURSION." HISTORICALLY, THIS WILL CHANGE ANY AMENDED REPORT THAT PREVIOUSLY INCLUDED THE PHRASE "SEVERELY THICKENED." NO PATIENT HARM HAS BEEN REPORTED. (B)(4). A REPORTABLE CORRECTION IS UNDERWAY FOR THIS ISSUE AND HAS BEEN REPORTED TO THE FDA. (B)(4). AGFA WILL FOLLOW THE RMAT POST MARKET VERIFICATION WORK INSTRUCTIONS TO CORRECT THE SENTENCE FINDING. ANY FURTHER INVESTIGATION FOR THE SITE DESCRIBED IN THIS REPORT WILL BE DOCUMENTED IN THE ONGOING CFR PART 806 REPORTING.
AGFA SUBMITTED MDR REPORT # 1225058-2010-00001 TO THE FDA ON FOR A SITE IN THE US. A 10TH OCCURRENCE IS BEING REPORTED FOR THE SAME ISSUE/SAME DEVICE: IMPAX CV RESULTS MANAGEMENT ADMINISTRATION TOOL (RMAT). THIS IS AN INTERNAL DISCOVERY DETERMINED DURING THE IMPLEMENTATION OF THE ASSOCIATED PROBLEM CORRECTION PLAN, RMAT VERIFICATION, AS REPORTED IN (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 355774 | IMPAX CV OUTBOUND (RESULTS MANAGEMENT 2.08) | PICTURE ARCHIVING AND COMMUNICATION | LLZ | AGFA HEALTHCARE CORP. | IMPAX CV RM 2.08 | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |